Sol-Gel Technologies (SLGL) Revenue (2018 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Revenue came in at $108000.0 in Q1 2026, down 89.52% year-on-year from $1.0 million in Q1 2025, and down 84.48% on a QoQ basis from $696000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Revenue (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of Revenue data on file, last reported at $108000.0 in Q1 2026.
- On a quarterly basis, Revenue fell 89.52% year-over-year to $108000.0 in Q1 2026; TTM through Mar 2026 was $18.5 million, a 52.57% increase from a year earlier, with the FY2025 full-year figure at $19.4 million, up 68.04% from the prior year.
- Revenue for Q1 2026 stood at $108000.0, down from $696000.0 in the prior quarter.
- Over the last five years, Revenue for SLGL reached as high as $3.0 billion in Q1 2022 and fell as low as $100000.0 in Q4 2022.
- Historically, Revenue has averaged $202.4 million across 5 years, with a median of $594000.0 in 2023.
- On a YoY basis, Revenue climbed as much as 427860.06% in 2022 and fell as far as 99.52% in 2022.
- Year by year, Revenue stood at $100000.0 in 2022, then surged by 347.0% to $447000.0 in 2023, then sank by 37.81% to $278000.0 in 2024, then surged by 150.36% to $696000.0 in 2025, then slumped by 84.48% to $108000.0 in 2026.
- Per Business Quant data, the three most recent Revenue figures were $108000.0 in Q1 2026, $696000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sol-Gel Technologies | 234.04 Mn | 223.91 Mn | - | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 696,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 594,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 3.00 Bn |
| Dec 31, 2021 | 20.81 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 701,000.00 |
| Dec 31, 2020 | 2.06 Mn |